Rx RadioRx Radio
HomePodcastResourcesShopNewsBusinessTechnologyClinical PracticeDrug Pricing & Access
HomePodcastResourcesShopArticlesCategoriesSearchAbout

Categories

NewsBusinessTechnologyClinical PracticeDrug Pricing & AccessEducationGlobal HealthLaw & ComplianceLeadership & DevelopmentManaged CarePatient Care & CounselingPublic HealthR&D
Rx RadioRx Radio

Leading the conversation in pharmacy

Navigation

  • Home
  • Podcast
  • Resources
  • Shop
  • Articles
  • Categories
  • Search

Categories

  • News
  • Business
  • Technology
  • Clinical Practice
  • Drug Pricing & Access
  • Education
  • Global Health

Company

  • About
  • Privacy Policy
  • Terms of Service

Follow Us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Threads

© 2026 Rx Radio. All rights reserved.

PrivacyTerms

Leif Hanson

Articles by Leif Hanson

Transforming STI Care: The Impact of FDA-Approved At-Home Testing
Patient Care & Counseling

Transforming STI Care: The Impact of FDA-Approved At-Home Testing

The FDA has authorized Visby Medical's at-home test for chlamydia, gonorrhea, and trichomoniasis, marking a major advancement in sexual health testing accessibility.

Roche's CT-388 Achieves 22.5% Weight Loss in Phase 2 Trial
News

Roche's CT-388 Achieves 22.5% Weight Loss in Phase 2 Trial

Roche's investigational obesity drug CT-388 demonstrated 22.5% placebo-adjusted weight loss at 48 weeks in Phase 2 trial, advancing to Phase 3 studies.